Showing results (1041-1050 of 2,331) with videos related to
Sort By:
Pageof 234
Clinical Drug Investigation|December 18, 2007
Gabapentin for decerebrate rigidity: a case reportChuen-Der Kao, Jen-Tse Chen, Kuan-Lin Lai, et al.Clinical Drug Investigation|October 11, 2016
Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid LeukemiaHui Liu, Rong Fu, Lijuan Li, et al.Clinical Drug Investigation|November 1, 2016
The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE StudyFrank R Ernst, Peri Barr, Riad Elmor, et al.Clinical Drug Investigation|March 11, 2014
Effect of hyaluronidase on the pharmacokinetics of free and total platinum species after intra-arterial Cisplatin in refractory patients with colorectal liver metastasesD Civalleri, M Esposito, F De Cain, et al.Clinical Drug Investigation|February 26, 2014
Pharmacokinetics of lacosamide and omeprazole coadministration in healthy volunteers: results from a phase I, randomized, crossover trialWilli Cawello, Christa Mueller-Voessing, Andreas FichtnerClinical Drug Investigation|March 19, 2008
Bioequivalence of clozapine orally disintegrating 100-mg tablets compared with clozapine solid oral 100-mg tablets after multiple doses in patients with schizophreniaGil Golden, Gilbert HonigfeldClinical Drug Investigation|January 31, 2014
Efficacy and safety of 1 % terbinafine film-forming solution in Chinese patients with tinea pedis: a randomized, double-blind, placebo-controlled, multicenter, parallel-group studyRuo Yu Li, A P Wang, J H Xu, et al.Clinical Drug Investigation|April 7, 2017
Current Clinical Trials on the Use of Ceftaroline in the Pediatric PopulationAdam Corey, Tsz-Yin SoClinical Drug Investigation|March 20, 2019
Time-Matched Evaluation of Cardiovascular Risks Associated with Drugs for Type 2 Diabetes MellitusMasayuki Kaneko, Mamoru NarukawaClinical Drug Investigation|April 8, 2017
Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral RegimensAmy Puenpatom, Michael Hull, Jeffrey McPheeters, et al.Pageof 234